# Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Parkinson's Disease

> **NCT03550183** · PHASE1 · UNKNOWN · sponsor: **Hebei Newtherapy BIo-Pharma technology Co., Ltd.** · enrollment: 20 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **BIOLOGICAL:** mesenchymal stem cells

## Key facts

- **NCT ID:** NCT03550183
- **Lead sponsor:** Hebei Newtherapy BIo-Pharma technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-10
- **Primary completion:** 2022-10-10
- **Final completion:** 2022-12-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03550183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03550183, "Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Parkinson's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03550183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*